Cover Image

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma

Background: Mechanisms of development and progression of high-grade serous ovarian cancer (HGSOC) are poorly understood. EVI1 and PARP1, part of TGF-ß pathway, are upregulated in cancers with DNA repair deficiencies with DNA repair deficiencies and may influce disease progression and survival. There...

Full description

Saved in:
Bibliographic Details
Main Authors: Jank, Paul (Author) , Leichsenring, Jonas (Author) , Kolb, Svenja (Author) , Hoffmann, Inga (Author) , Bischoff, Philip (Author) , Kunze, Catarina Alisa (Author) , Dragomir, Mihnea P. (Author) , Gleitsmann, Moritz (Author) , Jesinghaus, Moritz (Author) , Schmitt, Wolfgang D. (Author) , Kulbe, Hagen (Author) , Sers, Christine (Author) , Stenzinger, Albrecht (Author) , Sehouli, Jalid (Author) , Braicu, Ioana Elena (Author) , Westhoff, Christina (Author) , Horst, David (Author) , Denkert, Carsten (Author) , Gröschel, Stefan (Author) , Taube, Eliane T. (Author)
Format: Article (Journal)
Language:English
Published: 2023
In: Journal of ovarian research
Year: 2023, Volume: 16, Pages: 1-13
ISSN:1757-2215
DOI:10.1186/s13048-023-01239-6
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13048-023-01239-6
Verlag, kostenfrei, Volltext: https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-023-01239-6
Get full text
Author Notes:Paul Jank, Jonas Leichsenring, Svenja Kolb, Inga Hoffmann, Philip Bischoff, Catarina Alisa Kunze, Mihnea P. Dragomir, Moritz Gleitsmann, Moritz Jesinghaus, Wolfgang D. Schmitt, Hagen Kulbe, Christine Sers, Albrecht Stenzinger, Jalid Sehouli, Ioana Elena Braicu, Christina Westhoff, David Horst, Carsten Denkert, Stefan Gröschel and Eliane T. Taube

MARC

LEADER 00000caa a2200000 c 4500
001 1860962017
003 DE-627
005 20240307051454.0
007 cr uuu---uuuuu
008 231009s2023 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13048-023-01239-6  |2 doi 
035 |a (DE-627)1860962017 
035 |a (DE-599)KXP1860962017 
035 |a (OCoLC)1425210803 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jank, Paul  |e VerfasserIn  |0 (DE-588)1220462632  |0 (DE-627)1737383489  |4 aut 
245 1 0 |a High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma  |c Paul Jank, Jonas Leichsenring, Svenja Kolb, Inga Hoffmann, Philip Bischoff, Catarina Alisa Kunze, Mihnea P. Dragomir, Moritz Gleitsmann, Moritz Jesinghaus, Wolfgang D. Schmitt, Hagen Kulbe, Christine Sers, Albrecht Stenzinger, Jalid Sehouli, Ioana Elena Braicu, Christina Westhoff, David Horst, Carsten Denkert, Stefan Gröschel and Eliane T. Taube 
264 1 |c 2023 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 31. Juli 2023 
500 |a Gesehen am 09.10.2023 
520 |a Background: Mechanisms of development and progression of high-grade serous ovarian cancer (HGSOC) are poorly understood. EVI1 and PARP1, part of TGF-ß pathway, are upregulated in cancers with DNA repair deficiencies with DNA repair deficiencies and may influce disease progression and survival. Therefore we questioned the prognostic significance of protein expression of EVI1 alone and in combination with PARP1 and analyzed them in a cohort of patients with HGSOC. Methods: For 562 HGSOC patients, we evaluated EVI1 and PARP1 expression by immunohistochemical staining on tissue microarrays with QuPath digital semi-automatic positive cell detection. Results: High EVI1 expressing (> 30% positive tumor cells) HGSOC were associated with improved progression-free survival (PFS) (HR = 0.66, 95% CI: 0.504–0.852, p = 0.002) and overall survival (OS) (HR = 0.45, 95% CI: 0.352–0.563, p < 0.001), including multivariate analysis. Most interestingly, mutual high expression of both proteins identifies a group with particularly good prognosis. Our findings were proven technically and clinically using bioinformatical data sets for single-cell sequencing, copy number variation and gene as well as protein expression. Conclusions: EVI1 and PARP1 are robust prognostic biomarkers for favorable prognosis in HGSOC and imply further research with respect to their reciprocity. 
650 4 |a Biomarker 
650 4 |a EVI1 
650 4 |a HGSOC 
650 4 |a Ovarian cancer 
650 4 |a PARP 
650 4 |a Prognostic biomarker 
700 1 |a Leichsenring, Jonas  |e VerfasserIn  |4 aut 
700 1 |a Kolb, Svenja  |e VerfasserIn  |4 aut 
700 1 |a Hoffmann, Inga  |e VerfasserIn  |4 aut 
700 1 |a Bischoff, Philip  |e VerfasserIn  |4 aut 
700 1 |a Kunze, Catarina Alisa  |e VerfasserIn  |4 aut 
700 1 |a Dragomir, Mihnea P.  |e VerfasserIn  |4 aut 
700 1 |a Gleitsmann, Moritz  |e VerfasserIn  |4 aut 
700 1 |a Jesinghaus, Moritz  |e VerfasserIn  |4 aut 
700 1 |a Schmitt, Wolfgang D.  |e VerfasserIn  |4 aut 
700 1 |a Kulbe, Hagen  |e VerfasserIn  |4 aut 
700 1 |a Sers, Christine  |e VerfasserIn  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Sehouli, Jalid  |e VerfasserIn  |4 aut 
700 1 |a Braicu, Ioana Elena  |e VerfasserIn  |4 aut 
700 1 |a Westhoff, Christina  |e VerfasserIn  |4 aut 
700 1 |a Horst, David  |e VerfasserIn  |4 aut 
700 1 |a Denkert, Carsten  |e VerfasserIn  |4 aut 
700 1 |a Gröschel, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Taube, Eliane T.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of ovarian research  |d London : BioMed Central, 2008  |g 16(2023), Artikel-ID 150, Seite 1-13  |h Online-Ressource  |w (DE-627)581041070  |w (DE-600)2455679-8  |w (DE-576)286688778  |x 1757-2215  |7 nnas  |a High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma 
773 1 8 |g volume:16  |g year:2023  |g elocationid:150  |g pages:1-13  |g extent:13  |a High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma 
856 4 0 |u https://doi.org/10.1186/s13048-023-01239-6  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-023-01239-6  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20231009 
993 |a Article 
994 |a 2023 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 13 
999 |a KXP-PPN1860962017  |e 4382719607 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"pubHistory":["1.2008 -"],"title":[{"title":"Journal of ovarian research","subtitle":"JOR","title_sort":"Journal of ovarian research"}],"part":{"volume":"16","text":"16(2023), Artikel-ID 150, Seite 1-13","year":"2023","pages":"1-13","extent":"13"},"language":["eng"],"recId":"581041070","origin":[{"publisherPlace":"London","dateIssuedKey":"2008","dateIssuedDisp":"2008-","publisher":"BioMed Central"}],"titleAlt":[{"title":"JOR"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinomaJournal of ovarian research","id":{"eki":["581041070"],"issn":["1757-2215"],"zdb":["2455679-8"]},"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Veröffentlicht: 31. Juli 2023","Gesehen am 09.10.2023"],"physDesc":[{"noteIll":"Illustrationen","extent":"13 S."}],"id":{"eki":["1860962017"],"doi":["10.1186/s13048-023-01239-6"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"2023"}],"recId":"1860962017","person":[{"role":"aut","given":"Paul","display":"Jank, Paul","family":"Jank"},{"family":"Leichsenring","display":"Leichsenring, Jonas","given":"Jonas","role":"aut"},{"display":"Kolb, Svenja","role":"aut","given":"Svenja","family":"Kolb"},{"family":"Hoffmann","role":"aut","given":"Inga","display":"Hoffmann, Inga"},{"family":"Bischoff","given":"Philip","role":"aut","display":"Bischoff, Philip"},{"role":"aut","given":"Catarina Alisa","display":"Kunze, Catarina Alisa","family":"Kunze"},{"given":"Mihnea P.","role":"aut","display":"Dragomir, Mihnea P.","family":"Dragomir"},{"role":"aut","given":"Moritz","display":"Gleitsmann, Moritz","family":"Gleitsmann"},{"family":"Jesinghaus","given":"Moritz","role":"aut","display":"Jesinghaus, Moritz"},{"family":"Schmitt","role":"aut","given":"Wolfgang D.","display":"Schmitt, Wolfgang D."},{"role":"aut","given":"Hagen","display":"Kulbe, Hagen","family":"Kulbe"},{"family":"Sers","display":"Sers, Christine","given":"Christine","role":"aut"},{"family":"Stenzinger","role":"aut","given":"Albrecht","display":"Stenzinger, Albrecht"},{"display":"Sehouli, Jalid","given":"Jalid","role":"aut","family":"Sehouli"},{"family":"Braicu","display":"Braicu, Ioana Elena","role":"aut","given":"Ioana Elena"},{"family":"Westhoff","display":"Westhoff, Christina","given":"Christina","role":"aut"},{"family":"Horst","display":"Horst, David","given":"David","role":"aut"},{"given":"Carsten","role":"aut","display":"Denkert, Carsten","family":"Denkert"},{"family":"Gröschel","role":"aut","given":"Stefan","display":"Gröschel, Stefan"},{"role":"aut","given":"Eliane T.","display":"Taube, Eliane T.","family":"Taube"}],"name":{"displayForm":["Paul Jank, Jonas Leichsenring, Svenja Kolb, Inga Hoffmann, Philip Bischoff, Catarina Alisa Kunze, Mihnea P. Dragomir, Moritz Gleitsmann, Moritz Jesinghaus, Wolfgang D. Schmitt, Hagen Kulbe, Christine Sers, Albrecht Stenzinger, Jalid Sehouli, Ioana Elena Braicu, Christina Westhoff, David Horst, Carsten Denkert, Stefan Gröschel and Eliane T. Taube"]},"language":["eng"],"title":[{"title":"High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma","title_sort":"High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma"}]} 
SRT |a JANKPAULLEHIGHEVI1AN2023 

Similar Items